ARCHIVES

Program Announcements, RFA In Radiation Effects Available

This article is from The Cancer Letter archive.

Vol. 08 No. 37 | September 24, 1982

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

In Brief: Clarkson, Freireich Head AACR, ASCO; Oncology Nursing Society Membership Total Now 2,369

June 6, 1980

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

NCI, ACRIN Begin Trial Comparing Digital Mammography To Standard.

September 7, 2001

NCI-supported meeting included tobacco industry representatives in dialogue on ethics.

October 29, 2004

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014